SCHEMBL6270235

SCHEMBL6270235

Cn1cnc2c(N)nc(C3CC4CCC3C4)nc21

nearest known ligand 0.47

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 3/20 0.47
▸ ADORA2A P29274 3/20 0.40
▸ ADORA1 P30542 1/20 0.40
▸ BRD4 O60885 1/20 0.35
▸ CCNB1 P14635 1/20 0.34
▸ CCNE1 P24864 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ PIK3CA P42336 1/20 0.33
▸ ADORA2B P29275 1/20 0.33
▸ MAP3K12 Q12852 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9233825 1.00 CDK1 (0.47) CDK1ADORA2AADORA1BRD4CCNB1
SCHEMBL7437563 0.77 ADORA2A (0.31) ADORA2A
SCHEMBL9083885 0.77 ADORA2A (0.31) ADORA2A
SCHEMBL9082502 0.77 ADORA2A (0.40) ADORA2AADORA1ADORA2B
SCHEMBL7433611 0.76 PNP (0.47) ADORA2AADORA2B
SCHEMBL3089517 0.75 CDK1 (0.54) CDK1ADORA2AADORA1
SCHEMBL6270232 0.74 CDK1 (0.53) CDK1ADORA2AADORA1
SCHEMBL7205266 0.73 ADORA2A (0.63) ADORA2AADORA1ADORA2B
SCHEMBL6153485 0.72 ADORA1 (0.36) ADORA2AADORA1
SCHEMBL7437584 0.72 PDE8B (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0457773-A4 N?6 -SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS — 1993-03-10 — — EP claimed
EP-0457773-A1 N?6 -SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS WHITBY RESEARCH, Inc. (US) 1991-11-27 — — EP claimed
WO-1990009178-A1 N6-SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS WHITBY RESEARCH, INC. (US) 1990-08-23 — — WO claimed
EP-0778836-B1 SUBSTITUTED 9-ALKYLADENINES ADERIS PHARMACEUTICALS INC (US) 2005-12-28 — — EP disclosed
EP-1602657-A2 Substituted 9-alkyladenines Discovery Therapeutics, Inc. (US) 2005-12-07 — — EP disclosed
EP-0778836-A4 SUBSTITUTED 9-ALKYLADENINES DISCOVERY THERAPEUTICS INC (US) 1998-02-04 — — EP disclosed
EP-0778836-A1 SUBSTITUTED 9-ALKYLADENINES Discovery Therapeutics, Inc. (US) 1997-06-18 — — EP disclosed
WO-1996006845-A1 SUBSTITUTED 9-ALKYLADENINES DISCOVERY THERAPEUTICS, INC. (US) 1996-03-07 — — WO disclosed
EP-0457773-A4 N?6 -SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS — 1993-03-10 — — EP disclosed
EP-0457773-A1 N?6 -SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS WHITBY RESEARCH, Inc. (US) 1991-11-27 — — EP disclosed
WO-1990009178-A1 N6-SUBSTITUTED 9-METHYLADENINES: A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS WHITBY RESEARCH, INC. (US) 1990-08-23 — — WO disclosed
Send feedback